How to Approach Challenging Cases of Atopic Dermatitis

How to Approach Challenging Cases of Atopic Dermatitis


Supported by AbbVie


No announcements have been made for this course


Skill level: All levels
Release date: October 11, 2022




Multiple randomized, placebo-controlled and real-world studies have shown biologics to have high levels of efficacy, tolerability and safety for atopic dermatitis since approval. Yet, there are still patients who either don’t respond or lose response over time. Herein, we provide a framework on how to approach these patients including how to optimize add-on therapy to dupilumab and when to consider switching to an alternative therapy. A Q&A session is included in this discussion with Dr. James Song and guest speaker Dr. Andrew Blauvelt.

Learning Objectives
After completing this activity, participants will be able to:
  1. Review the work up and differential diagnosis for patients who are not adequate responders to dupilumab
  2. Discuss treatment options for patients with atopic dermatitis who are not adequate responders to dupilumab


This website – LearnSkin by LearnHealth Inc. is for education and information purposes only. This website is not to be used as a substitute for medical advice, diagnosis or treatment of health conditions or problem. The information provided on this website should never be used to disregard, delay or refuse treatment. The information provided here never replaces advice from a physician or a qualified health provider. LearnHealth Inc. makes no warranties nor express or implied representations whatsoever regarding the accuracy, completeness, timeliness, comparative or controversial nature, or usefulness of any information contained or referenced on this Website. LearnHealth Inc. does not assume any risk whatsoever for your use of this Website or the information contained herein. Health-related information changes frequently and therefore information contained on this Website may be outdated, incomplete or incorrect. Statements made about products may not have been evaluated by the Food and Drug Administration. Use of this Website does not create an expressed or implied physician-patient relationship.You are hereby advised to consult with a physician or other professional health care provider prior to making any decisions, or undertaking any actions or not undertaking any actions related to any health care problem or issue you might have at any time, now or in the future. In using this Website, you agree that neither LearnHealth Inc. nor any other party is or will be liable or otherwise be responsible for any decision made or any action taken or any action not taken due to your use of any information presented at this Website.